Iterating with the Insight of Expertise to Help Patients Feel Better, Longer
Olema is a clinical-stage biopharmaceutical company focused on transforming the metastatic breast cancer treatment paradigm and improving outcomes for patients living with breast cancer and beyond. We are advancing our pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Founded in 2006, Olema is headquartered in San Francisco, California and has operations in Cambridge, Massachusetts.
Item 1 of 6